Guillermo Moreno‐Sanz

1.3k total citations
26 papers, 1.0k citations indexed

About

Guillermo Moreno‐Sanz is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Guillermo Moreno‐Sanz has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 7 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Guillermo Moreno‐Sanz's work include Cannabis and Cannabinoid Research (23 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Sleep and Wakefulness Research (4 papers). Guillermo Moreno‐Sanz is often cited by papers focused on Cannabis and Cannabinoid Research (23 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Sleep and Wakefulness Research (4 papers). Guillermo Moreno‐Sanz collaborates with scholars based in United States, Italy and Spain. Guillermo Moreno‐Sanz's co-authors include Daniele Piomelli, Marco Mor, Giorgio Tarzia, Andrea Armirotti, Oscar Sasso, Andrea Duranti, Ana Guijarro, Tiziano Bandiera, Angelo Reggiani and Rosalia Bertorelli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Nature Neuroscience.

In The Last Decade

Guillermo Moreno‐Sanz

25 papers receiving 1.0k citations

Peers

Countries citing papers authored by Guillermo Moreno‐Sanz

Since Specialization

Citations

This map shows the geographic impact of Guillermo Moreno‐Sanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo Moreno‐Sanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo Moreno‐Sanz more than expected).

Fields of papers citing papers by Guillermo Moreno‐Sanz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillermo Moreno‐Sanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo Moreno‐Sanz. The network helps show where Guillermo Moreno‐Sanz may publish in the future.

Co-authorship network of co-authors of Guillermo Moreno‐Sanz

This figure shows the co-authorship network connecting the top 25 collaborators of Guillermo Moreno‐Sanz. A scholar is included among the top collaborators of Guillermo Moreno‐Sanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillermo Moreno‐Sanz. Guillermo Moreno‐Sanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NHS-Reimbursed Cannabis Flowers for Cancer Palliative Care and the Management of Chemotherapy-Induced Nausea and Vomiting: An Autobiographical Case Report 2024 ·Cureus ·Michael D. Roberts, Matthew Brown, Guillermo Moreno‐Sanz	1
2	Long-Term Treatment for Unspecified Anxiety Disorders with Cannabidiol: A Retrospective Case Series from Real-World Evidence in Colombia 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Guillermo Moreno‐Sanz	1
3	Controlled Inhalation of Tetrahydrocannabinol-Predominant Cannabis Flos Mitigates Severity of Post-Traumatic Stress Disorder Symptoms and Improves Quality of Sleep and General Mood in Cannabis-Experienced UK Civilians: A Real-World, Observational Study 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Guillermo Moreno‐Sanz	0
4	Sex-Dependent Prescription Patterns and Clinical Outcomes Associated With the Use of Two Oral Cannabis Formulations in the Multimodal Management of Chronic Pain Patients in Colombia 2022 ·SHILAP Revista de lepidopterología ·Guillermo Moreno‐Sanz, (unknown), Paula Hernández, (unknown), Oier Aizpurua‐Olaizola, Matthew Brown, (unknown), (unknown), (unknown)	11
5	Biological Activity of Cannabis sativa L. Extracts Critically Depends on Solvent Polarity and Decarboxylation 2020 ·Separations ·Guillermo Moreno‐Sanz, Carlos Ferreiro‐Vera, (unknown), (unknown), (unknown)	16
6	Self-Reported Effectiveness and Safety of Trokie® Lozenges: A Standardized Formulation for the Buccal Delivery of Cannabis Extracts 2018 ·Frontiers in Neuroscience ·(unknown), Sieta T. de Vries, Guillermo Moreno‐Sanz	11
7	Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPARα and CB₁ receptors 2017 ·British Journal of Pharmacology ·Erin M. Rock, Guillermo Moreno‐Sanz, Cheryl L. Limebeer, Gavin N. Petrie, Roberto Angelini, Daniele Piomelli, Linda A. Parker	16
8	Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury 2016 ·Cannabis and Cannabinoid Research ·Hamid Moradi, Fariba Oveisi, (unknown), Guillermo Moreno‐Sanz, Nosratola D. Vaziri, Daniele Piomelli	29
9	Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ ⁹ -Tetrahydrocannabinolic Acid A 2016 ·Cannabis and Cannabinoid Research ·Guillermo Moreno‐Sanz	69
10	Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse 2015 ·Neuropsychopharmacology ·Zuzana Justinová, Leigh V. Panlilio, Guillermo Moreno‐Sanz, Godfrey H. Redhi, (unknown), Maria E. Secci, Paola Mascia, Tiziano Bandiera, Andrea Armirotti, Rosalia Bertorelli, Svetlana I. Chefer, Chanel Barnes, Sevil Yaşar, Daniele Piomelli, Steven R. Goldberg	70
11	Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti‐inflammatory drug‐dependent gastrointestinal damage 2015 ·The FASEB Journal ·Oscar Sasso, Marco Migliore, Damien Habrant, Andrea Armirotti, Clara Albani, Maria Summa, Guillermo Moreno‐Sanz, Rita Scarpelli, Daniele Piomelli	57
12	Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 2014 ·Pharmacological Research ·Guillermo Moreno‐Sanz, (unknown), Andrea Armirotti, Sine Mandrup Bertozzi, Rita Scarpelli, Tiziano Bandiera, Julio G. Prieto, Andrea Duranti, Giorgio Tarzia, Gracia Merino, Daniele Piomelli	8
13	Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions 2012 ·Pharmacological Research ·Oscar Sasso, Rosalia Bertorelli, Tiziano Bandiera, Rita Scarpelli, Giampiero Colombano, Andrea Armirotti, Guillermo Moreno‐Sanz, Angelo Reggiani, Daniele Piomelli	76
14	Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models 2012 ·Pain ·Oscar Sasso, Guillermo Moreno‐Sanz, Cataldo Martucci, Natalia Realini, Mauro Dionisi, (unknown), Andrea Duranti, Glauco Tarozzo, Giorgio Tarzia, Marco Mor, Rosalia Bertorelli, Angelo Reggiani, Daniele Piomelli	83
15	Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood‐placenta barrier 2012 ·British Journal of Pharmacology ·Guillermo Moreno‐Sanz, Oscar Sasso, Ana Guijarro, (unknown), Rosalia Bertorelli, Angelo Reggiani, Daniele Piomelli	19
16	The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system 2011 ·Pharmacological Research ·Guillermo Moreno‐Sanz, (unknown), Ana Guijarro, (unknown), Jon A. Otero, Ana I. Álvarez, Tiziano Bandiera, Gracia Merino, Daniele Piomelli	21
17	Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism 2010 ·Nature Neuroscience ·Jason R. Clapper, Guillermo Moreno‐Sanz, Roberto Russo, Ana Guijarro, Federica Vacondio, Andrea Duranti, Andrea Tontini, Silvano Sanchini, Natale R. Sciolino, Jessica Marie Spradley, Andrea G. Hohmann, Antonio Calignano, Marco Mor, Giorgio Tarzia, Daniele Piomelli	268
18	Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement 2009 ·The International Journal of Neuropsychopharmacology ·Guillermo Moreno‐Sanz, Esther O’Shea, Laura Orío, Isabel Escobedo, Gustavo González‐Cuevas, Miguel Navarro, María Isabel Colado, José Antonio López‐Moreno	4
19	Pharmacological activation of CB1 and D2 receptors in rats: predominant role of CB1 in the increase of alcohol relapse 2008 ·European Journal of Neuroscience ·Francisco Alén, Guillermo Moreno‐Sanz, (unknown), (unknown), (unknown), Miguel Navarro, José Antonio López‐Moreno	21
20	Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-d-aspartate receptors 2008 ·Neuroscience ·Francisco Alén, Ángel Santos, Guillermo Moreno‐Sanz, Gustavo González‐Cuevas, Elena Giné, (unknown), Miguel Navarro, José Antonio López‐Moreno	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact